Arcutis Biotherapeutics, Inc. — Director's Dealing 2021

Feb 17, 2021

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Arcutis Biotherapeutics, Inc. (ARQT)
CIK: 0001787306
Period of Report: 2020-12-31

Reporting Person: OSBORNE DAVID W (Chief Technical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-18	Common Stock	G	12500	$0.00	Disposed	238033	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Indirect

Footnotes

F1: Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.

F2: Since it has been determined that the Reporting Person does not have voting or investment power over the (i) 62,478 shares held by The Osborne Irrevocable Trust FBO John Osborne and (ii) 62,478 shares held by The Osborne Irrevocable Trust FBO Sharon Osborne (together, the "Trusts"), is not the Trustee of said Trusts, and therefore is not deemed to beneficially own the Trust Shares, the Trust Shares will be excluded from the Reporting Person's future Section 16 reports.